Avanos Medical (NYSE:AVNS) Reaches New 12-Month Low – Here’s What Happened

Shares of Avanos Medical, Inc. (NYSE:AVNS) reached a new 52-week low during mid-day trading on Monday . The company traded as low as $15.51 and last traded at $15.65, with a volume of 460319 shares trading hands. The stock had previously closed at $15.55.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Trading Down 0.4 %

The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The stock has a market capitalization of $707.74 million, a P/E ratio of 45.29 and a beta of 0.99. The stock has a 50-day moving average price of $18.04 and a two-hundred day moving average price of $21.01.

Institutional Trading of Avanos Medical

Several institutional investors and hedge funds have recently bought and sold shares of AVNS. JPMorgan Chase & Co. lifted its position in Avanos Medical by 6.9% during the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company’s stock valued at $1,672,000 after buying an additional 4,472 shares during the period. Geode Capital Management LLC increased its stake in shares of Avanos Medical by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company’s stock worth $25,337,000 after acquiring an additional 16,065 shares in the last quarter. Barclays PLC lifted its position in Avanos Medical by 446.2% during the 3rd quarter. Barclays PLC now owns 96,194 shares of the company’s stock valued at $2,311,000 after acquiring an additional 78,583 shares during the period. Zacks Investment Management bought a new stake in Avanos Medical during the third quarter worth about $335,000. Finally, EP Wealth Advisors LLC purchased a new stake in Avanos Medical in the third quarter worth about $212,000. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.